W. Wold

发表

Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis

C. Ware, T. Horton, T. Ranheim, 1991, Journal of virology.

epidermal growth factor. sufficient to down regulate the receptor for is gene encoding an integral membrane protein Retrovirus-mediated transfer of an adenovirus

A. Ullrich, W. Wold, B. Hoffman, 2013 .

Retrovirus-mediated transfer of an adenovirus gene encoding an integral membrane protein is sufficient to down regulate the receptor for epidermal growth factor

W. Wold, B. Hoffman, C. Carlin, 1990 .

New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster

J. Sagartz, W. Wold, J. Spencer, 2009, Cancer Gene Therapy.

Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.

W. Wold, K. Toth, Karoly Toth, 2014, Current gene therapy.

Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway

Huan Ning, Gerald M. Wilson, G. M. Wilson, 2015, Oncotarget.

Adenovirus Type 2 Early Nuclear and mRNA: Kinetic Estimation of l and r DNA Strand Fractions Complementary to Different Abundance Classes of Viral RNA

W. Wold, M. Green, K. Brackmann, 1977, Journal of virology.

Adenovirus Methods and Protocols

W. Wold, 1998, Methods in Molecular Medicine™.

A fully replication-competent adenovirus vector with enhanced oncolytic properties

W. Wold, K. Toth, M. Kuppuswamy, 2010, Cancer Gene Therapy.

Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression

W. Wold, J. Spencer, K. Toth, 2005, Gene Therapy.

Adenovirus ADP protein (E3-11.6K), which is required for efficient cell lysis and virus release, interacts with human MAD2B.

W. Wold, B. Ying, 2003, Virology.

Nucleotide sequences of 5' termini of adenovirus 2 early transforming region E1a and E1b messenger ribonucleic acids.

W. Wold, K. Brackmann, S. Hashimoto, 1981, Biochemistry.

STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control

J. Sagartz, I. Kong, W. Wold, 2015, PLoS pathogens.

A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes

T. Horton, W. Wold, L. Gooding, 1990, Journal of virology.

Adenovirus type 2 coded single-stranded DNA binding protein: in vivo phosphorylation and modification

W. Wold, M. Green, K. Sugawara, 1977, Journal of virology.

A nonessential glycoprotein is coded by early region E3 of adenovirus type 7.

W. Wold, G. Chinnadurai, Q. S. Kapoor, 1981, Virology.

Male Syrian hamsters are more susceptible to intravenous infection with species C human adenoviruses than are females.

W. Wold, K. Toth, B. Ying, 2018, Virology.

An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector

L. Zumstein, D. Dhar, W. Wold, 2009, Cancer Gene Therapy.

Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model.

D. Dhar, W. Wold, K. Toth, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Effect of Preexisting Immunity on Oncolytic Adenovirus Vector INGN 007 Antitumor Efficacy in Immunocompetent and Immunosuppressed Syrian Hamsters

D. Dhar, W. Wold, K. Toth, 2008, Journal of Virology.

Anticancer activity of oncolytic adenovirus vector armed with IFN-α and ADP is enhanced by pharmacologically controlled expression of TRAIL

W. Wold, M. Kuppuswamy, E. Shashkova, 2008, Cancer Gene Therapy.

Adenovirus inhibition of immune-mediated apoptosis

W. Wold, D. Lichtenstein, K. Toth, 1999 .

Structures of the Oligosaccharides of the Glycoprotein Coded by Early Region E3 of Adenovirus 2

W. Wold, R. Kornfeld, 1981, Journal of virology.

Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5, and 6) human adenoviruses.

W. Wold, M. Green, J. Mackey, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Tumor Necrosis Factor α Increases Expression of Adenovirus E3 Proteins

F. Deryckère, W. Wold, H. Burgert, 1995 .

The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells

P. Duerksen-Hughes, W. Wold, L. Gooding, 1991, Journal of virology.

A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor

L. Elmore, W. Wold, L. Gooding, 1988, Cell.

Methylation of late adenovirus 2 nuclear and messenger RNA.

W. Wold, M. Green, T. Munns, 1976, Biochemical and biophysical research communications.

The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid

T. Ranheim, W. Wold, A. Stephenson, 1996, Journal of virology.

Inhibition of tumor necrosis factor and interferon triggered responses by DNA viruses.

W. Wold, P. Krajcsi, 1998, Seminars in cell & developmental biology.

121. Adenovirus Titers Determined by Quantitative Real-Time PCR Correlate with Infectious Titers

W. Wold, D. Lichtenstein, P. Krajcsi, 2006 .

Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes

R. Tripp, W. Wold, L. Gooding, 1993, Journal of virology.

[36] Human adenoviruses: Growth, purification, and transfection assay

W. Wold, Maurice Green, M. Green, 1979 .

The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.

P. Duerksen-Hughes, W. Wold, L. Gooding, 1990, Journal of immunology.

A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum

P. A. Peterson, S. Pääbo, W. Wold, 1987, Cell.

Cycles of Transient High-Dose Cyclophosphamide Administration and Oncolytic Adenovirus Vector Intratumoral Injection for Long Term Tumor Suppression in Syrian Hamsters

D. Dhar, W. Wold, K. Toth, 2014, Cancer Gene Therapy.

Thirty-one human adenovirus serotypes (Ad1-Ad31) form five groups (A-E) based upon DNA genome homologies.

W. Wold, M. Green, J. Mackey, 1979, Virology.

Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus

W. Wold, A. Scaria, H. Brady, 1992, Journal of virology.

A 6700 MW membrane protein is encoded by region E3 of adenovirus type 2.

S. K. Saha, W. Wold, L. Gooding, 1990, Virology.

Molecular mechanisms by which adenoviruses counteract antiviral immune defenses.

W. Wold, L. Gooding, 1990, Critical reviews in immunology.

Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor.

P. Duerksen-Hughes, W. Wold, L. Gooding, 1989, Journal of immunology.

Retrovirus-mediated transfer of an adenovirus gene encoding an integral membrane protein is sufficient to down regulate the receptor for epidermal growth factor

A. Ullrich, W. Wold, B. Hoffman, 1990, Molecular and cellular biology.

Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1A is immunodominant in H-2b, but not in H-2d or H-2k mice.

R. Ricciardi, P. Duerksen-Hughes, W. Wold, 1991, Journal of immunology.

ATTAAA as well as downstream sequences are required for RNA 3'-end formation in the E3 complex transcription unit of adenovirus

W. Wold, B. Bhat, 1985 .

ATTAAA as well as downstream sequences are required for RNA 3'-end formation in the E3 complex transcription unit of adenovirus.

W. Wold, B. Bhat, 1985, Molecular and cellular biology.

Mapping the 5' ends, 3' ends, and splice sites of mRNAs from the early E3 transcription unit of adenovirus 5.

W. Wold, C. Cladaras, B. Bhat, 1985, Virology.

Characterization of distinct 5'-terminal cap structures of adenovirus type 2 early messenger ribonucleic acid and KB cell messenger ribonucleic acid.

W. Wold, S. Hashimoto, M. Green, 1980, Biochemistry.

Adenovirus RIDβ Subunit Contains a Tyrosine Residue That Is Critical for RID-Mediated Receptor Internalization and Inhibition of Fas- and TRAIL-Induced Apoptosis

W. Wold, D. Lichtenstein, P. Krajcsi, 2002, Journal of Virology.

Introduction of cloned human papillomavirus genomes into mouse cells and expression at the RNA level.

W. Wold, G. Orth, M. Favre, 1983, Virology.

Adenovirus E3 Proteins: 14.7K, RID, and gp19K Inhibit Immune-Induced Cell Death; Adenovirus Death Protein Promotes Cell Death

W. Wold, A. Tollefson, 1998 .

Adenovirus proteins that subvert host defenses.

W. Wold, T. Hermiston, A. Tollefson, 1994, Trends in microbiology.

Mapping a new gene that encodes an 11,600-molecular-weight protein in the E3 transcription unit of adenovirus 2

W. Wold, C. Cladaras, N. Yacoub, 1984, Journal of virology.

Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters

J. Sagartz, R. Buller, W. Wold, 2015, Viruses.

Adenovirus E1A and E1B-19K proteins protect human hepatoma cells from transforming growth factor beta1-induced apoptosis.

W. Wold, V. Tarakanova, 2010, Virus research.

Increasing the Efficacy of Oncolytic Adenovirus Vectors

W. Wold, K. Toth, 2010, Viruses.

Inhibition of TRAIL-Induced Apoptosis and Forced Internalization of TRAIL Receptor 1 by Adenovirus Proteins

W. Wold, Craig A. Smith, D. Lichtenstein, 2001, Journal of Virology.

Role of early region 3 (E3) in pathogenesis of adenovirus disease.

R. Chanock, G. Prince, W. Wold, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression.

B. Trapnell, W. Wold, J. Whitsett, 1998, Human gene therapy.

A multitasking oncolytic adenovirus vector.

W. Wold, K. Toth, K. Doronin, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds

W. Wold, K. Toth, B. Ying, 2017, Antiviral research.

The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha

E. White, P. Sabbatini, D. Kusher, 1992, Molecular and cellular biology.

Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

J. Sagartz, N. Phillips, W. Wold, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds.

W. Wold, K. Toth, 2012, Advances in cancer research.

The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors

W. Wold, K. Toth, B. Ying, 2013, Cancer Gene Therapy.

A 14,500 MW protein is coded by region E3 of group C human adenoviruses.

W. Wold, L. Gooding, P. Krajcsi, 1990, Virology.

A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus

W. Wold, C. Carlin, P. Krajcsi, 1990, Journal of virology.

Virus deletion mutants that affect a 3' splice site in the E3 transcription unit of adenovirus 2

W. Wold, B. Bhat, H. Brady, 1985, Molecular and cellular biology.

Adenovirus replication–competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc)

P. Seth, N. Habib, W. Wold, 2002, Cancer Gene Therapy.

Simplex Virus Replication Superfamily Enzymes Suppress Herpes Inhibitors of Nucleotidyltransferase

J. Tavis, K. L. Davis, L. Morrison, 2014 .

Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus

W. Wold, B. Hoffman, C. Carlin, 1989, Cell.

STAT1 Interaction with E3-14.7K in Monocytes Affects the Efficacy of Oncolytic Adenovirus

N. Lemoine, W. Wold, Yaohe Wang, 2013, Journal of Virology.

Activation of intracellular proteases is an early event in TNF-induced apoptosis.

W. Wold, L. Gooding, S. Laster, 1995, Journal of immunology.

Filociclovir Is a Potent In Vitro and In Vivo Inhibitor of Human Adenoviruses

W. Wold, K. Toth, S. James, 2020, Antimicrobial Agents and Chemotherapy.

Drug development against human adenoviruses and its advancement by Syrian hamster models.

W. Wold, K. Toth, B. Ying, 2019, FEMS microbiology reviews.

Adenovirus E3-6.7K Protein Is Required in Conjunction with the E3-RID Protein Complex for the Internalization and Degradation of TRAIL Receptor 2

W. Wold, D. Lichtenstein, K. Toth, 2004, Journal of Virology.

Ganciclovir Inhibits Human Adenovirus Replication and Pathogenicity in Permissive Immunosuppressed Syrian Hamsters

R. Buller, S. Dewhurst, W. Wold, 2014, Antimicrobial Agents and Chemotherapy.

Deletion mutants that alter differential RNA processing in the E3 complex transcription unit of adenovirus.

W. Wold, B. Bhat, M. Pursley, 1986, Journal of molecular biology.

Adenovirus mutants with splice-enhancing mutations in the E3 complex transcription unit are also defective in E3A RNA 3'-end formation

W. Wold, B. Bhat, 1986, Journal of virology.

Detection of adenovirus type 2-induced early polypeptides using cycloheximide pretreatment to enhance viral protein synthesis

M. Harter, W. Wold, M. Green, 1976, Journal of virology.

Transforming Region of Group A, B, and C Adenoviruses: DNA Homology Studies with Twenty-Nine Human Adenovirus Serotypes

W. Wold, M. Green, J. Mackey, 1979, Journal of virology.

Adenovirus Death Protein (ADP) Is Required for Lytic Infection of Human Lymphocytes

W. Wold, L. Gooding, C. Garnett-Benson, 2013, Journal of Virology.

Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice.

W. Wold, P. Ward, K. Toth, 2005, Virus research.

Preparation and titration of CsCl-banded adenovirus stocks.

W. Wold, M. Kuppuswamy, E. Shashkova, 2007, Methods in molecular medicine.

Integration and transcription of group C human adenovirus sequences in the DNA of five lines of transformed rat cells.

W. Wold, M. Green, W. Büttner, 1981, Journal of molecular biology.

Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor.

W. Wold, L. Gooding, 1989, Molecular biology & medicine.

Regulation by zinc and adenosine 3',5'-cyclic monophosphate of growth and citric acid accumulation in Aspergillus niger.

W. Wold, I. Suzuki, 1976, Canadian journal of microbiology.

The citric acid fermentation by Aspergillus niger: regulation by zinc of growth and acidogenesis.

W. Wold, I. Suzuki, 1976, Canadian journal of microbiology.

Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions.

W. Wold, L. Gooding, L. R. Gooding, 1991, Virology.

Inhibitors of Nucleotidyltransferase Superfamily Enzymes Suppress Herpes Simplex Virus Replication

J. Tavis, K. L. Davis, L. Morrison, 2014, Antimicrobial Agents and Chemotherapy.

Demonstration in Aspergillus niger of adenyl cyclase, a cyclic adenosine 3',5'-monophosphate-binding protein, and studies on intracellular and extracellular phosphodiesterases.

W. Wold, I. Suzuki, 1974, Canadian journal of microbiology.

Analysis of human cancers, normal tissues, and verruce plantares for DNA sequences of human papillomavirus types 1 and 2.

W. Wold, G. Orth, M. Favre, 1981, Virology.

Cyclic AMP and citric acid accumulation by Aspergillus niger.

W. Wold, I. Suzuki, 1973, Biochemical and biophysical research communications.

Analysis of human cancer DNA's for DNA sequence of human adenovirus serotypes 3, 7, 11, 14, 16, and 21 in group B1.

W. Wold, M. Green, J. Mackey, 1979, Cancer research.

Analysis of Human Human Adenovirus Cancer DNA Type

W. Wold, Maurice Green, J. Mackey, 1979 .

Analysis of human tumors and human malignant cell lines for BK virus-specific DNA sequences.

W. Wold, M. Green, K. Brackmann, 1978, Proceedings of the National Academy of Sciences of the United States of America.

A real-time PCR method to rapidly titer adenovirus stocks.

W. Wold, D. Lichtenstein, P. Krajcsi, 2007, Methods in molecular medicine.

Tissue-Specific, Tumor-Selective, Replication-Competent Adenovirus Vector for Cancer Gene Therapy

W. Wold, K. Toth, P. Krajcsi, 2001, Journal of Virology.

Historic milestones in cancer virology.

W. Wold, M. Green, 1979, Seminars in oncology.

Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model

J. Sagartz, R. Buller, D. Dhar, 2008, Proceedings of the National Academy of Sciences.

USC‐087 protects Syrian hamsters against lethal challenge with human species C adenoviruses

W. Wold, E. Richard, C. McKenna, 2018, Antiviral research.

The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells

P. Duerksen-Hughes, T. Horton, L. Aquino, 1991, Journal of virology.

Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region.

W. Wold, D. Lichtenstein, K. Toth, 2002, Virology.

Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells

P. Doherty, R. Tripp, W. Wold, 1998, Nature.

E3 transcription unit of adenovirus.

W. Wold, T. Hermiston, A. Tollefson, 1995, Current topics in microbiology and immunology.

The E3-14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosylated but not N-glycosylated.

W. Wold, P. Krajcsi, A. Tollefson, 1992, Virology.

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants.

J. Ryerse, W. Wold, T. Hermiston, 1996, Virology.

The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells

J. Ryerse, W. Wold, T. Hermiston, 1996, Journal of virology.

cyt gene of adenoviruses 2 and 5 is an oncogene for transforming function in early region E1B and encodes the E1B 19,000-molecular-weight polypeptide

W. Wold, C. Cladaras, A. Conley, 1984, Journal of virology.

Identification of families of overlapping polypeptides coded by early "transforming" gene region 1 of human adenovirus type 2.

W. Wold, M. Green, K. Brackmann, 1979, Virology.

Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes

M. Hannink, W. Wold, P. Krajcsi, 1997, Journal of virology.

The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor

P. Duerksen-Hughes, T. Horton, T. Ranheim, 1991, Journal of virology.

Polypeptides encoded by transforming region E 1b of human adenovirus 2: immunoprecipitation from transformed and infected cells and cell-free translation of E 1b-specific mRNA.

W. Wold, M. Green, J. Symington, 1982, Virology.

Identification and peptide mapping of human adenovirus type 2-induced early polypeptides isolated by two-dimensional gel electrophoresis and immunoprecipitation.

W. Wold, K. Brackmann, M. Cartas, 1980, The Journal of biological chemistry.

Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus.

W. Wold, K. Toth, P. Krajcsi, 2003, Virology.

NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin

D. Bernstein, J. Domagala, W. Wold, 2022, Molecular pharmaceutics.

New drug on the horizon for treating adenovirus

W. Wold, K. Toth, 2015, Expert opinion on pharmacotherapy.

Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.

R. Buller, W. Wold, K. Toth, 2014, Antiviral research.

Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters

R. Klopfleisch, S. Pinkert, H. Fechner, 2017, Molecular therapy. Nucleic acids.

Generation and characterization of an Il2rg knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients

W. Wold, Yaohe Wang, K. Toth, 2020, Disease Models & Mechanisms.

HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model

W. Wold, K. Toth, B. Ying, 2017, Viruses.

Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5

J. Sagartz, W. Wold, K. Toth, 2017, Journal of Virology.

Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters

R. Aurora, W. Wold, K. Toth, 2015, Virology.

Syrian hamster tumor model to study oncolytic Ad5-based vectors.

D. Dhar, W. Wold, K. Toth, 2012, Methods in molecular biology.

Oncolytic (replication-competent) adenoviruses as anticancer agents

D. Dhar, W. Wold, K. Toth, 2010, Expert opinion on biological therapy.

INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies

L. Zumstein, D. Dhar, W. Wold, 2009, Cancer Gene Therapy.

Immunocompetent, semi-permissive cotton rat tumor model for the evaluation of oncolytic adenoviruses.

W. Wold, K. Toth, J. F. Spencer, 2007, Methods in molecular medicine.

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

D. Dhar, W. Wold, K. Toth, 2006, Cancer research.

Cotton rat tumor model for the evaluation of oncolytic adenoviruses.

G. Prince, W. Wold, D. Lichtenstein, 2005, Human gene therapy.

Identification of adenovirus 2 early region 4 polypeptides by in vitro translation and tryptic peptide map analysis

W. Wold, M. Green, J. Symington, 1982, Journal of virology.

Adenovirus type 2 early polypeptides immunoprecipitated by antisera to five lines of adenovirus-transformed rat cells

W. Wold, M. Green, 1979, Journal of virology.

Adenovirus-2 DNA: in vitro replication and analysis of viral early proteins.

T. Yamashita, W. Wold, M. Arens, 1979, Cold Spring Harbor symposia on quantitative biology.

Immunological identification of two adenovirus 2-induced early proteins possibly involved in cell transformation

M. Harter, W. Wold, H. Rho, 1976, Nature.

Genome expression and mRNA maturation at late stages of productive adenovirus type 2 infection

W. Wold, M. Green, K. Brackmann, 1976, Journal of virology.

The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor

S. K. Saha, W. Wold, A. Stewart, 1991, Journal of virology.

Chronic inflammatory bowel disease: absence of adenovirus DNA as established by molecular hybridization.

W. Wold, J. Roche, M. Green, 1981, Gastroenterology.

Ad proteins, RNA, lifecycle, host interactions, and phylogenetics

W. Wold, A. Tollefson, 2007 .

Identification of a New Human Adenovirus Protein Encoded by a Novel Late l-Strand Transcription Unit

W. Wold, B. Ying, K. Doronin, 2007, Journal of Virology.

Identiﬁcation of a New Human Adenovirus Protein Encoded by a Novel Late l -Strand Transcription Unit (cid:1)

W. Wold, B. Ying, K. Doronin, 2007 .

Ceramide regulates SR protein phosphorylation during adenoviral infection.

G. Dbaibo, C. Chalfant, W. Wold, 2006, Virology.

FUNCTIONS AND MECHANISMS OF ACTION OF THE ADENOVIRUS E3 PROTEINS

W. Wold, D. Lichtenstein, K. Toth, 2004, International reviews of immunology.

Identification and characterization of a 30K protein (Ad4E3-30K) encoded by the E3 region of human adenovirus type 4.

W. Wold, Y. Li, 2000, Virology.

Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

W. Wold, D. Lichtenstein, K. Toth, 1999, Current opinion in immunology.

The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model

R. Tripp, W. Wold, L. Gooding, 1996, Journal of virology.

Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis

T. Hermiston, P. Duerksen-Hughes, W. Wold, 1996, Journal of virology.

Region E3 of subgroup B human adenoviruses encodes a 16-kilodalton membrane protein that may be a distant analog of the E3-6.7K protein of subgroup C adenoviruses

W. Wold, J. Wilson-Rawls, L. Hawkins, 1995, Journal of virology.

The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane

W. Wold, P. Krajcsi, A. Stewart, 1995, Journal of virology.

Adenovirus genes that modulate the sensitivity of virus‐infected cells to lysis by TNF

W. Wold, William S. M. Wold, 1993, Journal of cellular biochemistry.

The E3-11.6K protein of adenovirus is an Asn-glycosylated integral membrane protein that localizes to the nuclear membrane.

S. K. Saha, W. Wold, A. Scaria, 1992, Virology.

A 12,500 MW protein is coded by region E3 of adenovirus.

W. Wold, L. Hawkins, Lynda K. Hawkins, 1992, Virology.

The adenovirus E3-14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine.

W. Wold, P. Krajcsi, 1992, Virology.

The E3-10.4K protein of adenovirus is an integral membrane protein that is partially cleaved between Ala22 and Ala23 and has a Ccyt orientation.

C. Anderson, W. Wold, C. Carlin, 1992, Virology.

Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K.

W. Wold, L. Gooding, A. Tollefson, 1989, Journal of immunology.

Competition between splicing and polyadenylation reactions determines which adenovirus region E3 mRNAs are synthesized

W. Wold, H. Brady, 1988, Molecular and cellular biology.

Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses

W. Wold, A. Tollefson, 1988, Journal of virology.

Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus.

W. Wold, H. Brady, 1987, Nucleic acids research.

Evidence that AGUAUAUGA and CCAAGAUGA initiate translation in the same mRNA region E3 of adenovirus.

W. Wold, S. Deutscher, B. Bhat, 1986, Virology.

Novel deletion mutants that enhance a distant upstream 5' splice in the E3 transcription unit of adenovirus 2.

W. Wold, S. Deutscher, C. Cladaras, 1985, Nucleic acids research.

DNA sequence of the early E3 transcription unit of adenovirus 5.

W. Wold, C. Cladaras, 1985, Virology.

Human adenoviruses: growth, purification, and transfection assay.

W. Wold, M. Green, 1979, Methods in enzymology.

Maurice Green - A pioneering virologist.

E. Green, W. Wold, P. Loewenstein, 2018, Virology.

Characterization of the adenovirus E3 protein that down-regulates the epidermal growth factor receptor. Evidence for intermolecular disulfide bonding and plasma membrane localization.

M. Yaffe, W. Wold, B. Hoffman, 1992, The Journal of biological chemistry.

Transforming Growth Factor β1 Receptor II Is Downregulated by E1A in Adenovirus-Infected Cells

W. Wold, V. Tarakanova, 2003, Journal of Virology.

Viral proteins that regulate cellular signalling.

W. Wold, P. Krajcsi, 1998, The Journal of general virology.

Evidence for intracellular down-regulation of the epidermal growth factor (EGF) receptor during adenovirus infection by an EGF-independent mechanism

W. Wold, B. Hoffman, C. Carlin, 1992, Journal of virology.

Functional Analysis of the Leukemia Protein ELL: Evidence for a Role in the Regulation of Cell Growth and Survival

A. Shilatifard, Mark F. Gerber, R. Johnstone, 2001, Molecular and Cellular Biology.

Identification of a Previously Unrecognized Promoter That Drives Expression of the UXP Transcription Unit in the Human Adenovirus Type 5 Genome

W. Wold, B. Ying, A. Tollefson, 2010, Journal of Virology.

“sarc” Sequence Transcription in Moloney Sarcoma Virus-Transformed Nonproducer Cell Lines

W. Wold, M. Bondurant, M. Green, 1979, Journal of virology.

Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission

W. Wold, D. Lichtenstein, 2004, Cancer Gene Therapy.

Immunofluorescence Study of the Adenovirus Type 2 Single-Stranded DNA Binding Protein in Infected and Transformed Cells

W. Wold, M. Green, K. Sugawara, 1977, Journal of virology.

The signal-anchor domain of adenovirus E3-6.7K, a type III integral membrane protein, can direct adenovirus E3-gp19K, a type I integral membrane protein, into the membrane of the endoplasmic reticulum.

W. Wold, S. Deutscher, J. Wilson-Rawls, 1994, Virology.

Evidence for an Adenovirus Type 2-Coded Early Glycoprotein

W. Wold, M. Green, Y. Jeng, 1978, Journal of virology.

Association of adenovirus type 2 early proteins with a soluble complex that synthesizes adenovirus DNA in vitro.

W. Wold, H. Rho, M. Green, 1977, Biochemical and biophysical research communications.

The 11,600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection

S. K. Saha, W. Wold, A. Scaria, 1992, Journal of virology.

Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors.

W. Wold, J. F. Spencer, Maria A. Thomas, 2007, Methods in molecular medicine.

Mutations within the ADP (E3-11.6K) Protein Alter Processing and Localization of ADP and the Kinetics of Cell Lysis of Adenovirus-Infected Cells

W. Wold, B. Ying, A. Scaria, 2003, Journal of Virology.

Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain.

R. Kladney, W. Wold, C. Fimmel, 2002, Virology.

Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor

T. Horton, T. Ranheim, W. Wold, 1993, Journal of virology.

An Oncolytic Adenovirus Vector Combining Enhanced Cell-to-Cell Spreading, Mediated by the ADP Cytolytic Protein, with Selective Replication in Cancer Cells with Deregulated Wnt Signaling

W. Wold, K. Toth, P. Krajcsi, 2004, Cancer Research.

Distinct Domains in the Adenovirus E3 RIDα Protein Are Required for Degradation of Fas and the Epidermal Growth Factor Receptor

W. Wold, D. Lichtenstein, S. Yei, 2003, Journal of Virology.

Identification and characterization of the herpes simplex virus type 2 gene encoding the essential capsid protein ICP32/VP19c

W. Wold, A. Conley, S. Yei, 1990, Journal of virology.

Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants

W. Wold, B. Bhat, 1986, Journal of virology.

The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model

W. Wold, K. Toth, B. Ying, 2013, Cancer Gene Therapy.

Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9

I. Kong, W. Wold, Yaohe Wang, 2018, Viruses.

Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma

J. Jessup, W. Wold, A. Tollefson, 2019, Human vaccines & immunotherapeutics.

Promotion of conidia aggregation in Aspergillus niger by cyclic AMP and 5'-GMP.

W. Wold, I. Suzuki, 1973, Biochemical and biophysical research communications.

Tumor-Specific, Replication-Competent Adenovirus Vectors Overexpressing the Adenovirus Death Protein

W. Wold, P. Ward, K. Toth, 2000, Journal of Virology.

A small deletion distant from a splice or polyadenylation site dramatically alters pre-mRNA processing in region E3 of adenovirus

W. Wold, B. Bhat, 1987, Journal of virology.

Identification of adenovirus type 12 candidate transformation proteins by radioimmunoprecipitation with antisera to EcoRI-C-fragment transformed cells.

W. Wold, G. Chinnadurai, M. Green, 1979, Virology.

The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides.

W. Wold, L. Hawkins, 1995, Virology.

A 20,500-Dalton protein is coded by region E3 of subgroup B but not subgroup C human adenoviruses.

W. Wold, L. Hawkins, 1995, Virology.

Conserved primary sequences of the DNA terminal proteins of five different human adenovirus groups.

W. Wold, J. Elder, M. Green, 1979, Proceedings of the National Academy of Sciences of the United States of America.

The 55K protein on the 5' termini of adenovirus type 2 DNA is unrelated to virus-coded candidate transformation proteins (E1-53K, E1-40K-50K) and DNA-binding proteins (E2-42K/47K/73K)

W. Wold, M. Green, K. Brackmann, 1979, Journal of virology.

Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.

W. Wold, Xiaoshan Jiang, T. Chambers, 2006, The Journal of general virology.

Studies on early proteins and transformation proteins of human adenoviruses.

W. Wold, K. Brackmann, M. Cartas, 1980, Cold Spring Harbor symposia on quantitative biology.

Targeting Interferon-α Increases Antitumor Efficacy and Reduces Hepatotoxicity of E1A-mutated Spread-enhanced Oncolytic Adenovirus.

W. Wold, E. Shashkova, J. F. Spencer, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

West Nile 25A virus infection of B-cell-deficient ((micro)MT) mice: characterization of neuroinvasiveness and pseudoreversion of the viral envelope protein.

W. Wold, T. Chambers, D. Droll, 2008, The Journal of general virology.

JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease.

W. Wold, Xiaoshan Jiang, T. Chambers, 2007, Virology.

Fine-mapping of sequences that suppress splicing in the E3 complex transcription unit of adenovirus.

W. Wold, A. Scaria, 1994, Virology.

Neuroadapted Yellow Fever Virus Strain 17D: a Charged Locus in Domain III of the E Protein Governs Heparin Binding Activity and Neuroinvasiveness in the SCID Mouse Model

W. Wold, T. Chambers, D. Droll, 2008, Journal of Virology.

The Virology of Taterapox Virus In Vitro

E. Lefkowitz, C. A. Bonjardim, R. Buller, 2018, Viruses.

The10,400- and14,500-Dalton Proteins EncodedbyRegionE3of Adenovirus Function Together ToProtect ManybutNotAllMouse CellLinesagainst LysisbyTumorNecrosis Factor

T. Horton, T. Ranheim, W. Wold, 1991 .

The 19-kDa glycoprotein coded by region E3 of adenovirus. Purification, characterization, and structural analysis.

W. Wold, S. Deutscher, C. Cladaras, 1985, The Journal of biological chemistry.

Integration Pattern of Human JC Virus Sequences in Two Clones of a Cell Line Established from a JC Virus-Induced Hamster Brain Tumor

W. Wold, B. Padgett, D. Walker, 1980, Journal of virology.

Correction: STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control

J. Sagartz, I. Kong, W. Wold, 2016, PLoS pathogens.

Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus.

W. Wold, E. Shashkova, J. F. Spencer, 2007, Molecular Therapy.

Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein

J. Dawson, W. Wold, P. Ward, 2003, Cancer Gene Therapy.

Construction of Mutations in the Adenovirus Early Region 3 (E3) Transcription Units

W. Wold, T. Hermiston, A. Tollefson, 1999 .

DNA sequences affecting specific initiation of transcription in vitro from the EIII promoter of adenovirus 2.

R. Roeder, W. Wold, D. C. Lee, 1982, Proceedings of the National Academy of Sciences of the United States of America.

The E3-6.7K protein of adenovirus is an Asn-linked integral membrane glycoprotein localized in the endoplasmic reticulum.

W. Wold, J. Wilson-Rawls, 1993, Virology.